City

Cincinnati (1)

Indianapolis (1)

Saint Louis (1)

San Francisco (1)

Condition

Atrioventricular Septal Defect (3)

Ventricular Septal Defect (2)

Atrial Septal Defect (1)

Heart Septal Defects, Ventricular (1)

Primum Atrial Septal Defect (1)

Overall Status

Completed (1)

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 3 (1)

Sponsor

Asklepion Pharmaceuticals, LLC (2)

University of California, San Francisco (1)

Collaborator

Intervention

intravenous l-citrulline (1)

iv l-carnitine (1)

l-citrulline (1)

placebo of intravenous l-citrulline (1)

plasmalyte a (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

atrioventricular septal defect

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Ventricular Septal Defect, Atrioventricular Septal Defect, Primum Atrial Septal Defect Trial in Indianapolis (L-citrulline,

Recruiting

Ventricular Septal Defect
+2 more

L-citrulline
Plasmalyte A

Indianapolis, Indiana

Riley Hospital for Children at Indiana University Health

Jul 25, 2022

Atrial Septal Defect, Ventricular Septal Defect, Atrioventricular Septal Defect Trial in Saint Louis, Cincinnati (Intravenous

Completed

Atrial Septal Defect
+2 more

Intravenous L-Citrulline
Placebo of Intravenous L-Citrulline

Saint Louis, Missouri
+1 more

Jul 21, 2022

Heart Septal Defects, Ventricular, Atrioventricular Septal Defect Trial in San Francisco (IV L-carnitine)

Withdrawn

Heart Septal Defects, Ventricular
Atrioventricular Septal Defect

IV L-carnitine

San Francisco, California

University of California San Francisco

May 4, 2020